AmCham-IMSS deal pledges US $44 million to bring clinical trials to Mexican public hospitals

AI Summary

AmCham and IMSS have agreed on a US $44 million deal to introduce clinical trials into Mexican public hospitals. This initiative aims to broaden the scope of medical research and improve the availability of new medication testing beyond private institutions in Mexico.

The vast majority of clinical trials in Mexico for testing, among other things, the safety and efficacy of new medications, take place in private hospitals. AmCham and IMSS are looking to change that. The post AmCham-IMSS deal pledges US $44 million to bring clinical trials to Mexican public hospitals appeared first on Mexico News Daily